A 57% Profit Leap and a 15% Stock Slide: The Munich Re Paradox

Munich Re's Q1 profit surged 57% to €1.714bn, yet shares slid 15% amid market concerns over disciplined underwriting and price cuts; a €2.25bn buyback and insider purchases signal confidence.

For a company that just booked its strongest quarterly profit in years, Munich Re’s share price is behaving as if the opposite were true. The stock closed Friday at €475.10 — a session gain of 1.41%, but still down 5.7% on the week and a full 15% below where it traded a month ago. That divergence between operational excellence and market sentiment is sharpening the focus on the boardroom’s latest moves.

The counter-punch came in two forms. On 14 May, the Dax-listed reinsurer began the first tranche of its share buyback programme, setting aside up to €900m to repurchase its own stock through the end of August. The programme as a whole, announced on 29 April, runs to €2.25bn and extends until the 2027 annual general meeting. Days later, board member Andrew Buchanan added his own vote of confidence, picking up a package of shares worth around €172,000. He joins several other executives who have taken advantage of the recent dip.

Under the hood, the numbers tell a story of disciplined underwriting rather than top-line expansion. Net profit surged 57% in the first quarter to €1.714bn, up from €1.094bn a year earlier, as large-loss costs collapsed to just €130m. The combined ratio in property and casualty reinsurance improved dramatically to 66.8% from 83.9%, while the Solvency II ratio stood at a towering 292% — giving management ample capital to return to shareholders and to reject business that does not meet return thresholds.

That last point is at the heart of the market’s unease. In the 1 April renewal round, Munich Re deliberately slashed the volume it wrote in property and casualty reinsurance by 18.5%, and prices in that segment fell 3.1% like-for-like. The company’s mantra of “value before volume” means walking away from unprofitable contracts even when competitors are chasing growth. The stock’s recent slide reflects investor worry that this discipline could cap earnings momentum relative to peers such as Hannover Re and Swiss Re.

The long-term strategy, however, is to wean the group off its historic dependence on volatile natural catastrophe exposure. Chief executive Christoph Jurecka is steering the portfolio so that the primary insurance arm ERGO, life reinsurance, and specialty lines contribute roughly 60% of group earnings. ERGO itself added €235m to first-quarter net profit, and a cost-cutting programme aiming at €600m in annual savings by 2030 — powered by artificial intelligence and process automation — is expected to provide an increasingly stable second leg to the group’s income.

Analysts are split on what the stock is worth. Goldman Sachs trimmed its price target to €557 with a neutral rating, while Jefferies remains bullish at €600, arguing that the renewal pressure is already priced in and that Munich Re’s capital strength is an underappreciated moat. The full-year profit target of €6.3bn remains unchanged, and the company has also set aside a prudent provision for potential financial fallout from the conflict in the Persian Gulf.

Technically, the shares are dancing on a knife edge. At Friday’s close, they sat barely 2% above the 52-week low. The combination of an active buyback, insider buying, and a capital ratio that screams resilience now forms the first line of defence against further selling pressure. Whether the market will reframe the volume cuts as strategic strength rather than defensive retreat is the question hanging over the coming trading week.